{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T13:57:10Z","timestamp":1776952630952,"version":"3.51.4"},"reference-count":85,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Toxicology"],"published-print":{"date-parts":[[2025,11,26]]},"DOI":"10.1080\/10408444.2025.2600331","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T15:30:30Z","timestamp":1769787030000},"page":"982-994","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Risk assessment of trace hydrazine in a 2020 bottled water-associated nonviral hepatitis outbreak"],"prefix":"10.1080","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0440-5384","authenticated-orcid":false,"given":"Blake M.","family":"Deckard","sequence":"first","affiliation":[{"name":"TRC Strategic Health Sciences Division","place":["Jackson, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5771-3234","authenticated-orcid":false,"given":"Kylie M.","family":"McCauley","sequence":"additional","affiliation":[{"name":"TRC Strategic Health Sciences Division","place":["Jackson, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7134-5442","authenticated-orcid":false,"given":"Michael E.","family":"Stevens","sequence":"additional","affiliation":[{"name":"TRC Strategic Health Sciences Division","place":["Jackson, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-2045","authenticated-orcid":false,"given":"David W.","family":"Brew","sequence":"additional","affiliation":[{"name":"TRC Strategic Health Sciences Division","place":["Jackson, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7412-7731","authenticated-orcid":false,"given":"Dennis J.","family":"Paustenbach","sequence":"additional","affiliation":[{"name":"TRC Strategic Health Sciences Division","place":["Jackson, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"5","key":"e_1_3_3_2_1","first-page":"365","article-title":"The pharmacokinetics of isoniazid in children (author\u2019s transl)","volume":"9","author":"Advenier C","year":"1981","unstructured":"Advenier C, Saint-Aubin A, Scheinmann P, Paupe J. 1981. The pharmacokinetics of isoniazid in children (author\u2019s transl). Rev Fr Mal Respir. 9(5):365\u2013374.","journal-title":"Rev Fr Mal Respir"},{"key":"e_1_3_3_3_1","first-page":"113","volume-title":"Hydrazines, Agency for Toxic Substances and Disease Registry","author":"Agency for Toxic Substances and Disease Registry (ATSDR)","year":"1997","unstructured":"Agency for Toxic Substances and Disease Registry (ATSDR). 1997a. Production, import, use, and disposal. In: Hydrazines, Agency for Toxic Substances and Disease Registry. p. 113\u2013118."},{"key":"e_1_3_3_4_1","unstructured":"Agency for Toxic Substances and Disease Registry (ATSDR). 1997b. Toxicological profile for hydrazines. U. S. Department of Health and Human Services Public Health Service Agency for Toxic Substances and Disease Registry. p. 1\u2013224."},{"key":"e_1_3_3_5_1","unstructured":"Agency for Toxic Substances and Disease Registry (ATSDR). 2025. Public Health Assessment Guidance Manual: calculating Hazard Quotients and Cancer Risk Estimates. Agency for Toxic Substances and Disease Registry."},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01532-13"},{"key":"e_1_3_3_7_1","article-title":"Coverage of isoniazid preventive therapy (IPT) among people living with HIV (PLHIV) registered at ART centre in a public health facility of Western India","author":"Bhatt JH","year":"2023","unstructured":"Bhatt JH, Mehta K, Chaudhari A, Chavda P, Kagathara N. 2023. Coverage of isoniazid preventive therapy (IPT) among people living with HIV (PLHIV) registered at ART centre in a public health facility of Western India. Indian J Tuberc. 72(1):12\u201318.","journal-title":"Indian J Tuberc"},{"issue":"4","key":"e_1_3_3_8_1","first-page":"943","article-title":"Hepatomas in CBA\/Cb\/Se mice and liver lesions in golden hamsters induced by hydrazine sulfate","volume":"44","author":"Biancifiori C.","year":"1970","unstructured":"Biancifiori C. 1970. Hepatomas in CBA\/Cb\/Se mice and liver lesions in golden hamsters induced by hydrazine sulfate. J Natl Cancer Inst. 44(4):943\u2013953.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/096032718500400210"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2016.25.167.10060"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.87.10.840"},{"key":"e_1_3_3_12_1","unstructured":"Centers for Disease Control and Prevention (CDC). 2025. About Inactive Tuberculosis. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/tb\/about\/inactive-tuberculosis.html"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0045-6535(98)00088-5"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvr274"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/106002809402801202"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365510260389985"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(73)90015-9"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2019.04.012"},{"key":"e_1_3_3_19_1","unstructured":"Eurofins Eaton Analytical. 2023. Analytical Report: job Description Drinking Water Project-Nevada. Eurofins Eaton Analytical South Bend. p. 1\u201353."},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02614227"},{"key":"e_1_3_3_21_1","unstructured":"FDA. 2021. (March Food and Drug Administration (FDA). 2021. Investigation of Acute Non-viral Hepatitis Illnesses - \u201cReal Water\u201d Brand Alkaline Water. Food and Drug Administration. https:\/\/www.fda.gov\/food\/outbreaks-foodborne-illness\/investigation-acute-non-viral-hepatitis-illnesses-real-water-brand-alkaline-water-march-2021"},{"key":"e_1_3_3_22_1","unstructured":"Food and Drug Administration (FDA). 2022. Summary Report For Product Name: water and Ice N.E.C.; Nonflex Plastic; Packaged Food (Not Commercially Sterile). Food and Drug Administration Office of Regulatory Affairs. March 4 2022:1\u201310."},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.5.2.231"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01740658"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/01635588109513694"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-5-728_2"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.32102"},{"key":"e_1_3_3_28_1","first-page":"191","volume-title":"Hydrazine. International Agency for Research on Cancer","author":"International Agency for Research on Cancer (IARC)","year":"2018","unstructured":"International Agency for Research on Cancer (IARC). 2018. Hydrazine. International Agency for Research on Cancer. p. 191\u2013245."},{"key":"e_1_3_3_29_1","volume-title":"Hydrazine toxicology","author":"Ivanov I","year":"2023","unstructured":"Ivanov I, Lee VR. 2023. Hydrazine toxicology. Stat Pearls Publishing."},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-023-03562-9"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31825c4bc3"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000232"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)24211-2"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1086\/598192"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.355"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.68.2.181"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-84-2-181"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200006000-00076"},{"key":"e_1_3_3_39_1","volume-title":"Intentional Human Dosing Studies for EPA Regulatory Purposes: scientific and Ethical Issues","author":"National Research Council (NRC)","year":"2004","unstructured":"National Research Council (NRC). 2004. Appendix A: values and Limitations of Animal Toxicity Data. In Intentional Human Dosing Studies for EPA Regulatory Purposes: scientific and Ethical Issues. National Academies Press."},{"key":"e_1_3_3_40_1","volume-title":"15th Report on Carcinogens","author":"National Toxicology Program (NTP)","year":"2021","unstructured":"National Toxicology Program (NTP). 2021. Hydrazine and Hydrazine Sulfate CAS Nos. 302-01-2 and 10034-93-2. In 15th Report on Carcinogens. Research Triangle Park, NC, National Toxicology Program."},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.35.2538"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.11.1014"},{"key":"e_1_3_3_43_1","unstructured":"O\u2019Connor C Patel P Brady MF. 2024. Isoniazid. In. StatPearls Publishing."},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781119742975.ch4"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00637563"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(92)80123-8"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/096032719201100211"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.04.021"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cancerbio-041916-065808"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5472.1246-a"},{"key":"e_1_3_3_51_1","unstructured":"Revchuk A. 2023. Expert Report of Alex Revchuk D. Env. P.E. BCES In the matter of Gallagher Orion et\u00a0al. vs Real Water Case No. A-21-834485-B Dept. No. XVI Case No. A831169 (Lead Case). Exponent Inc. March 24 p. 1\u2013209."},{"key":"e_1_3_3_52_1","first-page":"1","volume-title":"Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology, and Laboratory Services","author":"Ruff J.","year":"2021","unstructured":"Ruff J. 2021. Unusual hepatitis outbreak linked to a brand of alkaline bottled water. Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology, and Laboratory Services. December 14, 2021. p. 1\u201352."},{"key":"e_1_3_3_53_1","first-page":"1","volume-title":"Mitigating an Unknown Threat: acute Nonviral Hepatitis Linked to a Brand of Alkaline Bottled Water","author":"Ruff J.","year":"2022","unstructured":"Ruff J. 2022. Mitigating an Unknown Threat: acute Nonviral Hepatitis Linked to a Brand of Alkaline Bottled Water. Centers for Disease Control and Prevention. May 3, 2022. p. 1\u201340."},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7046a6"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161140-00003"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1986.133.6.1072"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.052175"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000084372.91932.BA"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.6622"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)33119-3"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1515\/reveh-2022-0057"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05429-11"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1080\/15287398209530309"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.05207.x"},{"issue":"1","key":"e_1_3_3_65_1","first-page":"133","article-title":"A slow-release preparation of isoniazid: therapeutic efficacy and adverse side-effects","volume":"51","author":"Tripathy SP.","year":"1976","unstructured":"Tripathy SP. 1976. A slow-release preparation of isoniazid: therapeutic efficacy and adverse side-effects. Bull Int Union Tuberc. 51(1):133\u2013141.","journal-title":"Bull Int Union Tuberc"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1021\/ie50528a020"},{"issue":"4","key":"e_1_3_3_67_1","first-page":"455","article-title":"The prevention and treatment of isoniazid toxicity in the therapy of pulmonary tuberculosis: 1. An assessment of two vitamin B preparations and glutamic acid","volume":"28","author":"Tuberculosis Chemotherapy Centre","year":"1963","unstructured":"Tuberculosis Chemotherapy Centre. 1963a. The prevention and treatment of isoniazid toxicity in the therapy of pulmonary tuberculosis: 1. An assessment of two vitamin B preparations and glutamic acid. Bull World Health Organ. 28(4):455\u2013475.","journal-title":"Bull World Health Organ"},{"issue":"4","key":"e_1_3_3_68_1","first-page":"457","article-title":"The prevention and treatment of isoniazid toxicity in the therapy of pulmonary tuberculosis: 2. An assessment of the prophylactic effect of pyridoxine in low dosage","volume":"29","author":"Tuberculosis Chemotherapy Centre","year":"1963","unstructured":"Tuberculosis Chemotherapy Centre. 1963b. The prevention and treatment of isoniazid toxicity in the therapy of pulmonary tuberculosis: 2. An assessment of the prophylactic effect of pyridoxine in low dosage. Bull World Health Organ. 29(4):457\u2013481.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_3_69_1","volume-title":"U.S. Environmental Protection Agency (EPA) NCfEA, Integrated Risk Information System (IRIS),","author":"U.S. Environmental Protection Agency (EPA)","year":"1988","unstructured":"U.S. Environmental Protection Agency (EPA). 1988. Hydrazine\/Hydrazine sulfate; CASRN 302-01-2. U.S. Environmental Protection Agency (EPA) NCfEA, Integrated Risk Information System (IRIS),. U.S. Environmental Protection Agency (EPA),."},{"key":"e_1_3_3_70_1","unstructured":"U.S. Environmental Protection Agency (EPA). 2000. Hydrazine: 302-02-1. U. S. Environmental Protection Agency. 1\u20134."},{"key":"e_1_3_3_71_1","unstructured":"U.S. Environmental Protection Agency (EPA). 2009. Provisional Peer-Reviewed Toxicity Values for Hydrazine (CASRN 302-01-2). Superfund Health Risk Technical Support Center National Center for Environmental Assessment Office of Research and Development U.S. Environmental Protection Agency. p. 1\u201344."},{"key":"e_1_3_3_72_1","first-page":"1","volume-title":"exposure Factors Handbook: 2011 Edition","author":"U.S. Environmental Protection Agency (EPA)","year":"2011","unstructured":"U.S. Environmental Protection Agency (EPA). 2011a. Body Weight Studies. In: exposure Factors Handbook: 2011 Edition,. U.S. Environmental Protection Agency. p. 1\u201356."},{"key":"e_1_3_3_73_1","first-page":"1","volume-title":"National Center for Environmental Assessment, Office of Research and Development","author":"U.S. Environmental Protection Agency (EPA)","year":"2011","unstructured":"U.S. Environmental Protection Agency (EPA). 2011b. Exposure Factors Handbook. 2011 Edition. National Center for Environmental Assessment, Office of Research and Development,. U.S. Environmental Protection Agency. p. 1\u20131436.","edition":"2011"},{"key":"e_1_3_3_74_1","first-page":"1","volume-title":"National Center for Environmental Assessment, Office of Research and Development","author":"U.S. Environmental Protection Agency (EPA)","year":"2019","unstructured":"U.S. Environmental Protection Agency (EPA). 2019. Update for Chapter 3 of the Exposure Factors Handbook: ingestion of Water and Other Select Liquids. In National Center for Environmental Assessment, Office of Research and Development,. U.S. Environmental Protection Agency. p. 1\u2013157."},{"key":"e_1_3_3_75_1","unstructured":"U.S. Environmental Protection Agency (EPA). 2025. Conducting a Human Health Risk Assessment. U.S. Environmental Protection Agency. https:\/\/www.epa.gov\/risk\/conducting-human-health-risk-assessment"},{"key":"e_1_3_3_76_1","unstructured":"U. S. Food & Drug Administration. 2021. Real Water Inc. issues precautionary recall of all sizes of real water brand drinking water due to a possible health risk. https:\/\/www.fda.gov\/safety\/recalls-market-withdrawals-safety-alerts\/real-water-inc-issues-precautionary-recall-all-sizes-real-water-brand-drinking-water-due-possible"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/0272-0590(85)90141-1"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2016.07.014"},{"issue":"1","key":"e_1_3_3_79_1","first-page":"51","article-title":"Hydrazine - a possible cause of isoniazid - induced hepatic necrosis","volume":"23","author":"Woo J","year":"1992","unstructured":"Woo J, Chan CH, Walubo A, Chan KK. 1992. Hydrazine - a possible cause of isoniazid - induced hepatic necrosis. J Med. 23(1):51\u201359.","journal-title":"J Med"},{"key":"e_1_3_3_80_1","volume-title":"Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children","author":"World Health Organization (WHO)","year":"2014","unstructured":"World Health Organization (WHO). 2014. Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children. 2nd edn. World Health Organization.","edition":"2"},{"key":"e_1_3_3_81_1","unstructured":"World Health Organization (WHO). 2020a. Concept Note. Dose optimization of rifampicin isoniazid pyrazinamide and ethambutol in the treatment of drug-susceptible tuberculosis. World Health Organization. p. 1\u20138."},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.30978\/TB2021-2-86"},{"key":"e_1_3_3_83_1","first-page":"1","volume-title":"WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment","author":"World Health Organization (WHO)","year":"2022","unstructured":"World Health Organization (WHO). 2022. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment. World Health Organization. p. 1\u201372."},{"key":"e_1_3_3_84_1","first-page":"83","article-title":"A clinical trial of orally administered alkaline reduced water","volume":"13","author":"Yang EJ","year":"2007","unstructured":"Yang EJ et\u00a0al. 2007. A clinical trial of orally administered alkaline reduced water. J Biomed Sci. 13:83\u201389.","journal-title":"J Biomed Sci"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/1521654031000153049"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270011402826"}],"container-title":["Critical Reviews in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10408444.2025.2600331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T13:28:09Z","timestamp":1776950889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10408444.2025.2600331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":85,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,11,26]]}},"alternative-id":["10.1080\/10408444.2025.2600331"],"URL":"https:\/\/doi.org\/10.1080\/10408444.2025.2600331","relation":{},"ISSN":["1040-8444","1547-6898"],"issn-type":[{"value":"1040-8444","type":"print"},{"value":"1547-6898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itxc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itxc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}